期刊文献+

人内皮抑素基因的克隆以及在大肠杆菌中的可溶性表达研究 被引量:1

Research about Soluble Expression of Human Endostatin in E.coli
下载PDF
导出
摘要 用PCR的方法从人胎肝cDNA文库中得到人内皮抑素基因 ,克隆测序正确后连接到硫氧还蛋白融合表达载体上 ,转化大肠杆菌BL2 1 (DE3)得到表达人内皮抑素的工程菌。用IPTG诱导表达 ,表达量达到全菌蛋白的 64%。经分析硫氧还蛋白可以辅助内皮抑素可溶性表达 ,表达的融合蛋白保持了天然蛋白的免疫学特性。而且表面带有多聚组氨酸的突变的硫氧还蛋白还简化了蛋白纯化的步骤 ,使融合蛋白可以通过固相金属螯和层析 (IMAC)的方法纯化。纯化后的融合蛋白经IgA蛋白酶的切割可得到大小正确的重组人内皮抑素 ,用此方法获得的重组人内皮抑素可以在CAM试验中抑制新生血管的形成。高效可溶型表达内皮抑素的工程菌的构建成功 。 Endostatin is a potent,endogenous inhibitor of angiogenesis,which corresponds to the C-terminal fragment of collagen XVIII.cDNA coding for human endostatin was obtained from a human fetal liver cDNA library using PCR ,After subcloned into the express vector pETTrxHisL and subsequenced to prove its correctness, pETTrxHisL-endostatin was transformed to E.coli BL21(DE3).The fusion protein Trx-Endostatin was expressed as soluble form,and can be purified by IMCA (Immobilized metal affinity chromatography) method.The SDS-PAGE thin layer scanning analysis found expression level was more than 64% total protein,and the Mol.Weight was about 31.5kDa.Western blot analysis indicate the immunoreactive was identical with natural hEndostatin.Biological activity was confirmed by CAM angiogenesis assay,the soluble human endostatin expressed by E.coli is potent to inhibit the angiogenesis in CAM.;
出处 《中国生物工程杂志》 CAS CSCD 2004年第9期39-43,共5页 China Biotechnology
关键词 重组人内皮抑素 可溶性表达 融合蛋白 硫氧还蛋白 人内皮抑素基因 胎肝 人胎 IPTG 诱导表达 纯化 Endostatin Thioredoxin Soluble expression Anti-angiogenesis
  • 相关文献

参考文献9

  • 1Folkman J. How is blood vessel growth regulated in normal and neoplastic tissue? Clowes G H A. memorial award lecture. Cancer Res, 1986,46: 467 - 473
  • 2Boehm T, Folkman J, Browder T, et al. Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance.Nature, 1997,390 (6658): 404 - 407
  • 3O' Reilly M S, Boehm T, Folkman J, et al. Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell, 1997,88(2) :277 - 285
  • 4Dhanabal M, Ramchandran R, Volk R, et al. Endostatin: yeast production,mutants,and antitumor effect in renal cell carcinoma.Cancer Res, 1999,59( 1 ): 189 - 197
  • 5Dhanabal M, Volk R, Ramchandran R, et al. Cloning, expression,and in vitro activity of human endostatin. Biochem Biophys Res Commun, 1999,258 ( 2 ): 345 - 352
  • 6Suk P O H, Matthew L Warman, Michael F Seldin, et al. Cloning of cDNA and genomic DNA encoding human type ⅩⅧ collagen and localization of the α1 (ⅩⅧ)collagen gene to mouse chromosome 10 and human chromosome 21
  • 7Harris T J R. Expression of eukaryotic gene in E. coli. In: Genetic engineering,WilliamsenR, Ed. 127 - 185,1983
  • 8McCoy M. A thioredoxin gene fusion system that circumvents inclusion body formation in E. coli. Biotechnology, 1993,11:187 -193
  • 9冯怡,崔立斌,刘传暄,马清钧.人内皮抑素在毕赤酵母中的表达、纯化与生物功能研究[J].生物工程学报,2001,17(3):278-282. 被引量:15

二级参考文献18

  • 1[1]Folkman J. How is blood vessel growth regulated in normal and neo plastic tissue? G. H. A. Clowes memorial award lecture. Cancer Res,1986,46:467~473
  • 2[2]Folkman J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med, 1995,1: 27~31
  • 3[3]Folkman J. Tumor angiogenesis: therapeutic implications. N Engl J Med, 1971,18(285): 1182~1186
  • 4[4]Kerbel R S. A cancer therapy resistant to resistance. Nature, 1997,390 (6658): 335~336
  • 5[5]Hanahan D. A flanking attack on cancer, Nat Medd, 1998,4(1): 13~14
  • 6[6]Timothy Browder, Bwtterfield CE, Kraling BM et al. Antiangiogenic scheduling of chemotherapy improves efficacy against experimental drug-resistant eance. Cancer Res ,2000,60:1878~1886
  • 7[7]O' Reilly M S, Boehm T et al. Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell, 1997,88(2) :277~285
  • 8[8]Sasaki T, Fkai N et al. Structure, function and tissue forms of the C-terminal globular domain of collagen XVIII containing the angiogenesis inhibitor endostatin. EMBO J, 1998,17 (15): 4249~4256
  • 9[9]Dhanabal M, Ramchandran R, Waterman M J, Endostatin induces endothelial cell apoptosis. J Biol Chem, 1999,274 (17): 11721~11726
  • 10[10]Dhanabal m, Volk r, Ramchandran R. Cloning, expression, and in vitro activity of human endostatin. Biochem Biophys Res Commun,1999,258(2) :345~352

共引文献15

同被引文献6

  • 1Yang J P, Hori M, Sanda T, et al. Identification of a novel inhibitor of nuclear factor-kappaB, RelA-associated inhibitor. J Biol Chem, 1999,274(22): 15662 - 15670.
  • 2Bergamaschi D, Samuels Y, O' Neil N J, et al. iASPP oncoprotein is a key inhibitor of p53 conserved from worm to human. Nat Genet, 2003, 33(2) : 162 - 167.
  • 3Zhang X, Wang M, Zhou C, et al. The expression of iASPP in acute leukemias. Leuk Res, 2005,29(2) :179 - 83.
  • 4Liu Z J, Zhang Y, Zhang X B, et al. Abnormal mRNA expression of ASPP members in leukemia cell lines. Leukemia, :2004,18(4) :880.
  • 5Qian M, Chen S, Li X, et al. Cloning and expression of human UDP-glucuronosyltransferase 1A4 in Bar-to-Bar system. Bioehem Biophys Res Commun 2004,319(2) : 386 - 392.
  • 6高瀛岱,熊冬生,彭晖,许元富,邵晓枫,范冬梅,杨纯正.抗Pgp基因工程抗体ScFv的构建、表达及其活性测定[J].中国免疫学杂志,2004,20(4):267-271. 被引量:3

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部